Case Western Reserve University School of Medicine research, published in the journal Science, show that use of a drug currently prescribed to treat cancer appears to reverse Alzheimer’s symptoms in mice. Results point to significant potential that the medication, bexarotene, may help the roughly 5.4 million Americans with the progressive brain disease. This a great example of drug “repurposing” discussed here a couple days ago.
Crain’s Cleveland Business did a nice write-up on the researchers, Gary Landreth and Paige Cramer, and their newly formed company, ReXceptor, Inc. And this video produced by Case does an excellent job of explaining the research.
